扫码关注公众号           扫码咨询技术支持           扫码咨询技术服务
  
客服热线:400-901-9800  客服QQ:4009019800  技术答疑  技术支持  质量反馈  关于我们  联系我们
产品中心-北京博奥森生物技术有限公司
首页 > 产品中心 > 一抗 > 产品信息
MIG7 Rabbit pAb (bs-5781R)  
订购热线:400-901-9800
订购邮箱:sales@bioss.com.cn
订购QQ:  400-901-9800
技术支持:techsupport@bioss.com.cn
50ul/1180.00元
100ul/1980.00元
200ul/2800.00元
大包装/询价
产品编号 bs-5781R
英文名称 MIG7 Rabbit pAb
中文名称 富含半胱氨酸蛋白质MIG7抗体
别    名 mig 7; mig-7.  
Specific References  (1)     |     bs-5781R has been referenced in 1 publications.
[IF=3.309] Ren K et al. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.Exp Cell Res. 2018 Aug 1;369(1):80-89.  IHC-P&WB ;  Human.  
研究领域 肿瘤  心血管  免疫学  生长因子和激素  细胞类型标志物  
抗体来源 Rabbit
克隆类型 Polyclonal
交叉反应 (predicted: Human)
产品应用 WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ELISA=1:5000-10000
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
理论分子量 22 kDa
检测分子量
细胞定位 细胞膜 
性    状 Liquid
浓    度 1mg/ml
免 疫 原 KLH conjugated synthetic peptide derived from human MIG7: 51-150/207 
亚    型 IgG
纯化方法 affinity purified by Protein A
缓 冲 液 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
保存条件 Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事项 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
产品介绍 MIG7 is a cysteine-rich protein found in cell membranes and cytoplasm of carcinoma cells. Tumor tissue and blood from over 200 cancer patients have been shown to express MIG7, regardless of tissue origin. In contrast, it has not been detectable in tissues or blood from normal subjects. Expression of MIG7 seems to be restricted to carcinoma cells and putatively to the early placenta (Cytotrophoblast) and it's expression is important for the invasive capabilities of tumor cells.

Database links:

GenBank: ABF71424.1

SwissProt: Q1AHR6 Human



版权所有 2004-2026 www.bioss.com.cn 北京博奥森生物技术有限公司
通过国际质量管理体系ISO 9001:2015 GB/T 19001-2016    证书编号: 00124Q34771R2M/1100
通过国际医疗器械-质量管理体系ISO 13485:2016 GB/T 42061-2022    证书编号: CQC24QY10047R0M/1100
京ICP备05066980号-1         京公网安备110107000727号